| Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. |
| Highlights: |
| View the latest trials here. |
| A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish. Support equal access to nephrology research: Become an ISN Member! |
Kidney International® Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and... read more
Kidney International® The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis People... read more
ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes... read more
The mystery of chronic kidney disease of unknown origin (CKDu) continues... read more
From global policy tools to community-driven projects and early-career development, ISN's... read more
ISN-ACT Global Trials Focus editorial team member Michele Provenzano summarizes the design... read more
Why do millions of people worldwide still face limited access to... read more
Kidney International® Identifying strategies for disseminating research to patients with chronic kidney... read more
Through robust data collection, international collaboration, and practical insights, the 2023... read more
Watch the video for an animated explanation of the study based... read more
